Bank Of New York Mellon Corp Biodesix Inc Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.32 - $2.12 $39,213 - $62,978	-29,707 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$1.69 - $5.81 $261 - $900	155 Added 0.52%	29,707 $50,000
Q4 2021 Feb 11, 2022	BUY	$4.09 - $8.67 $2,605 - $5,522	637 Added 2.2%	29,552 $156,000
Q3 2021 Nov 12, 2021	SELL	$6.6 - $12.78 $7,590 - $14,697	-1,150 Reduced 3.83%	28,915 $237,000
Q2 2021 Aug 11, 2021	BUY	$12.14 - $20.35 $197,444 - $330,972	16,264 Added 117.85%	30,065 $397,000
Q1 2021 May 13, 2021	BUY	$16.87 - $31.21 $45,127 - $83,486	2,675 Added 24.04%	13,801 $280,000
Q4 2020 Feb 09, 2021	BUY	$10.89 - $20.16 $121,162 - $224,300	11,126 New	11,126 $224,000

62.3M

2.6K

10.1K

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $55.2M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.